Robert Broyles
Biochemisty
EpimedX
United States of America
Biography
Dr. Broyles is co-founder and Chief Science Officer of EpimedX. He discovered and developed Gene Regulation Therapy© for sickle cell disease, the basis of EpimedX’s current platform, and he is the primary inventor on the patents licensed by EpimedX. Dr. Broyles earned a PhD in Biochemistry from Wake Forest University and obtained postdoctoral training with a National Institute of Health fellowship at Florida State University, and he currently holds appointments in the Department of Biochemistry & Molecular Biology and the Department of Pediatrics at the University of Oklahoma Health Sciences Center. Dr. Broyles has been a pioneer in sickle cell research for over 40 years and is the founder and acting President of the Sickle Cell Cure Foundation.
Research Interest
biochemistry
